Weekly Update, December 13, 2006

• AMARAmarillo Biosciences To Start Phase 2 Oral Warts Study; Reiterate Speculative Buy
• AMARAmarillo Biosciences Speculative Buy Rating Reiterated in Update Report
• AMGIAmerican Mold Guard's AMG Scientific Services Could Provide One Solution for Reducing Virus Outbreaks Aboard Cruise Ships.
• AMPXAmpex: Institutional Holder Files SEC Form 13D amendment on Ampex Corporation Common Stock;Strong Buy Rating Reiterated & Price Target Increased to $35.00
• APNSApplied NeuroSolutions Maintains Strong Speculative Buy Rating; Recently-announced Agreement With Eli Lilly and Company For Alzheimer's disease.
• APPAfrican Platinum: Record Platinum Price of $1400 Per Ounce May Have Only Limited Short Term Affect on African Platinum Shares
• AVGNAvigen Announces Completion of Phase I Clinical Trial for AV650 - Documentation That the Company is Meeting Our Timelines
• BIPHBiophan Appoints Mr. Stan Yakatan to Board of Directors;Strong Speculative Buy Rating Reiterated
• CEMIChembio Diagnostics At Strong Speculative Buy Rating In Update
• CLRIClearant, Inc. Signs Distribution Agreement For Northeast.
• CLRIClearant Direct Distribution Sales at Record Level in November; New Strategy Continues to Gain Traction.
• CLRIClearant, Inc. Announces Supply Agreement for Direct Distribution of Soft Tissue. Neutral Rating Reiterated.
• CPEUBluePoint Energy, Inc. and Starwood Hotels Expand Relationship; Strong Speculative Buy Reiterated; Raising Price Target
• CPEUBluePoint Energy, Inc. and Starwood Hotels Expand Relationship;Strong Speculative Buy Reiterated; Raising Price Target
• CRVHChilco River Holdings Neutral Rating Maintained In Update Coverage; Adding New Venues For Business In Latin America
• DXPEDXP Enterprises Stock Volatility Appears Technically-Driven; Reiterate Strong Buy Rating Based on Attractive Fundamentals
• ELRNElron: Positive Developments Continue, Sells Remaining Holdings in Partner Communications for $40 million
• ELRNElron Group Company Jordan Valley Semiconductors, Inc. Expects 100% Growth in Bookings for 2006; Lands Order From Major DRAM Manufacturer
• EPMEvolution Petroleum Strong Buy Rating Maintained;Over The Longer Term, We Expect Proved Reserves To Exceed 10x Present Levels.
• FORGForgent Networks, Inc. Reports Positive Results for First-Quarter FY2007; Stock Responds to Profitable Quarter
• FORGForgent Networks, Inc. Will Announce 2007 Fiscal First Quarter Earnings on December 8, 2006;Conference Call Scheduled
• HYDGHydroGen Corporation: Presentation Highlights 2006 Accomplishments and 2007 Objectives. Speculative Buy Reiterated.
• HYDPHydrogen Power International Neutral Rating Maintained; Important Advantages Relative To Existing Methods Of Hydrogen Production.
• IGLDInternet Gold Buy Rating Maintained and Price Target Raised; Now Expect 2007E Revenues of US$260.7 million and EPS of US$0.81 As Result of Scope of the Synergies Between the Two Companies Post Merger
• INKSInksure Technologies: Downgrading to Speculative Buy on Share Price Increase, New Target of USD $3.50.
• JADELJ International Lowered To Speculative Buy Rating; No Alteration In Our View That LJI's Long-Term Revenue And Earnings Growth Prospects Are Bright
• LGTYLogility Reports 17% Increase in Operating Earnings
• LMECLime Energy Co. Stock Under Tax-Selling Pressure; Raising Rating to Strong Speculative Buy and Price Target to $2.00 per share.
• MDVMedivation Raises $34 million From Stock Placement; Reiterate Strong Speculative Buy
• MDVMedivation Strong Speculative Buy Rating In Update; Recent Phase 2 Clinical Results For The Treatment Of Alzheimer's Disease Are Compelling
• MDVMedivation Expands Senior Management Team; Reiterate Strong Speculative Buy
• MDWMidway Gold Announces Acquisition
• MDWMidway Gold 2006 Drill Program Expands Spring Creek Deposit
• ONIOragenics Calls In Warrants To Provide Needed Funding; Reiterate Speculative Buy
• ONIOragenics Scientists Describe Antibiotic Research In New Textbook; Reiterate Speculative Buy
• ONIOragenics Files Patent For Unique TB Gene Targets; Reiterate Speculative Buy
• PHLIPacificHealth Laboratories Speculative Buy Rating Reiterated in Update Report
• PLRSPluristem Life Sciences Speculative Buy Rating In Update Coverage; Invited To Present Data At The American Society of Hematology (ASH) on December 10, 2006
• PPDAPipeline Data Rating Maintained At Strong Buy; Spent Three Years Building Itself Into A Significant Player In Credit Card Transaction Processing.
• PTSCPatriot Scientific Announces Additional Licensee;Stock Under Year-End Tax-Selling Pressure
• SESISES Solar Speculative Buy Rating In Update Coverage; Well Positioned To Benefit From Soaring Demand For Solar Energy In Europe And Worldwide
• SESISES Solar Inc.: Tougher Emissions Restrictions in Europe Could Boost Demand for Solar Energy Long Term.
• SMFSmart & Final New Store Opening Brings Total to 253; Buy Reiterated
• SUWNSunwin International Neutraceuticals Contracts Leading Scientist to Advance the Development of Hypericin-based Products for Combating Avian Flu Virus; Reiterate Strong Speculative Buy Rating
• SWRISeawright Holdings Rating Speculative Buy In Initiating Coverage; Water Has Become One Of The Biggest Businesses At A Global Level
• TCHC21st Century Raises Dividend 50%:Strong Buy Rating Reiterated: Increasing Price Target to $35.00 Per Share
• TESAmerican Telecom Services - We Believe Shares Significantly Undervalued - Raising our Estimates Due to Expected Very Strong December Quarter Revenues
• TISATop Image Systems Buy Rating And Increased Target Price; Consolidating Position As A Leading Content Capture Player; Particular Strength in High-potential Unstructured Content Capture market.
• TNXITelanetix On Track for December Quarter
• XARXAAR Issues a Positive Trading Update: We Reiterate Our Strong Buy